South Korea Cracks Down on 'Dream Drug' Investment Hype

South Korea is requiring pharmaceutical companies to back up their claims with hard data, ending an era of misleading "dream drug" promotions that lured investors with unrealistic promises.

The new rules protect everyday investors from inflated expectations about experimental medicines.